Literature DB >> 15086597

Barrett's esophagus: prevalence and its relationship with dyspeptic symptoms.

Murat Toruner1, Irfan Soykan, Arzu Ensari, Isinsu Kuzu, Cihan Yurdaydin, Ali Ozden.   

Abstract

BACKGROUND AND AIM: Barrett's metaplasia is a premalign condition which plays a pivotal role in the development of esophageal adenocarcinoma. It is considered a complication of chronic gastroesophageal reflux disease. Although esophageal adenocarcinoma is an uncommon cancer, its incidence is rapidly increasing. The aims of the present study were to determine the prevalence of Barrett's metaplasia in outpatients referred for gastroscopy for upper gastrointestinal symptoms, and to clarify the relationship between Barrett's metaplasia and upper gastrointestinal symptoms.
METHODS: Three-hundred and ninety-five consecutive dyspeptic patients, never previously investigated, underwent gastroscopy and were enrolled into the study.
RESULTS: Barrett's metaplasia was detected in 29 patients (7.4%). The age-specific prevalence of Barrett's metaplasia increased with age. In multivariate analysis, Barrett's metaplasia was independently and positively related to age, sex and duration of symptoms, but not with upper gastrointestinal symptoms. In univariate analysis, Barrett's metaplasia was significantly more common in patients with antral intestinal metaplasia (24%) and presence of hiatal hernia (65.5%), compared with those with normal endoscopic findings (6.2% and 39.2%, respectively, p = 0.001).
CONCLUSION: Symptoms do not predict Barrett's metaplasia. Barrett's metaplasia is age-related and more common in patients with a longer duration of symptoms, presence of hiatal hernia and antral intestinal metaplasia.

Entities:  

Mesh:

Year:  2004        PMID: 15086597     DOI: 10.1111/j.1440-1746.2003.03342.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  14 in total

1.  Barrett's esophagus and the increasing role of endoluminal therapy.

Authors:  Michael S Smith; Charles J Lightdale
Journal:  Therap Adv Gastroenterol       Date:  2008-09       Impact factor: 4.409

2.  The global prevalence of Barrett's esophagus: A systematic review of the published literature.

Authors:  Inês Marques de Sá; Pedro Marcos; Prateek Sharma; Mário Dinis-Ribeiro
Journal:  United European Gastroenterol J       Date:  2020-07-06       Impact factor: 4.623

Review 3.  Meta-analyses of the effect of symptoms of gastroesophageal reflux on the risk of Barrett's esophagus.

Authors:  Justin B Taylor; Joel H Rubenstein
Journal:  Am J Gastroenterol       Date:  2010-05-18       Impact factor: 10.864

4.  Utility of endoscopy for diagnosis of barrett in a non-Western society: endoscopic and histopathologic correlation.

Authors:  Bahadır Ege; Tolga Dinç; Baris D Yildiz; Zeynep Balci; Hakan Bozkaya
Journal:  Int Surg       Date:  2015-01-14

5.  Alginates: From the ocean to gastroesophageal reflux disease treatment.

Authors:  Serhat Bor; İsmail Hakkı Kalkan; Altay Çelebi; Dinç Dinçer; Filiz Akyüz; Peter Dettmar; Hasan Özen
Journal:  Turk J Gastroenterol       Date:  2019-09       Impact factor: 1.852

6.  Gastroesophageal reflux disease symptom severity, proton pump inhibitor use, and esophageal carcinogenesis.

Authors:  Katie S Nason; Promporn Paula Wichienkuer; Omar Awais; Matthew J Schuchert; James D Luketich; Robert W O'Rourke; John G Hunter; Cynthia D Morris; Blair A Jobe
Journal:  Arch Surg       Date:  2011-07

7.  Clinical epidemiology of gastric cancer in Hehuang valley of China: a 10-year epidemiological study of gastric cancer.

Authors:  Su Yan; Bin Li; Zhen-Zhong Bai; Jun-Qi Wu; Da-Wei Xie; Ying-Cai Ma; Xu-Xiang Ma; Jun-Hui Zhao; Xin-Jian Guo
Journal:  World J Gastroenterol       Date:  2014-08-14       Impact factor: 5.742

8.  The association between Barrett's esophagus and Helicobacter pylori infection: a meta-analysis.

Authors:  Lori A Fischbach; Helena Nordenstedt; Jennifer R Kramer; Subi Gandhi; Sam Dick-Onuoha; Anthony Lewis; Hashem B El-Serag
Journal:  Helicobacter       Date:  2012-03-20       Impact factor: 5.753

Review 9.  Prevalence of Barrett's Esophagus in Asian Countries: A Systematic Review and Meta-analysis.

Authors:  Seiji Shiota; Siddharth Singh; Ashraf Anshasi; Hashem B El-Serag
Journal:  Clin Gastroenterol Hepatol       Date:  2015-08-07       Impact factor: 11.382

10.  Esophageal ulcer in a patient who received bevacizumab.

Authors:  Judith Meza-Junco; Clarence Wong; Anthony Fields; Michael B Sawyer
Journal:  Invest New Drugs       Date:  2009-03-31       Impact factor: 3.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.